Evidence map›Paper›PMID 30459303›Full record

ArticleCell death & disease2018

Correction to: ZIKA virus elicits P53 activation and genotoxic stress in human neural progenitors similar to mutations involved in severe forms of genetic microcephaly.

Vincent El Ghouzzi, Federico T Bianchi, Ivan Molineris, Bryan C Mounce, Gaia E Berto, Malgorzata Rak, Sophie Lebon, Laetitia Aubry, Chiara Tocco, Marta Gai and 8 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Human Brain Organoids to Decode Mechanisms of Microcephaly.Frontiers in cellular neuroscience · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Vincent El GhouzziPROTECT, INSERM, Unversité Paris Diderot, Sorbonne Paris Cité, Paris, France.
Federico T BianchiDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Turin, Turin, Italy.
Ivan MolinerisDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Turin, Turin, Italy.
Bryan C MounceInstitut Pasteur, Centre National de la RechercheScientifique UMR 3569, Viral Populations and Pathogenesis Unit, Paris, France.
Gaia E BertoDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Turin, Turin, Italy.
Malgorzata RakPROTECT, INSERM, Unversité Paris Diderot, Sorbonne Paris Cité, Paris, France.
Sophie LebonPROTECT, INSERM, Unversité Paris Diderot, Sorbonne Paris Cité, Paris, France.
Laetitia AubryUEVE UMR 861, I-Stem, AFM, Evry, France.
Chiara ToccoDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Turin, Turin, Italy.
Marta GaiDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Turin, Turin, Italy.
Alessandra M A ChiottoDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Turin, Turin, Italy.
Francesco SgròDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Turin, Turin, Italy.
Gianmarco PallaviciniDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Turin, Turin, Italy.
Etienne Simon-LoriereInstitut Pasteur, Functional Genetics of Infectious Diseases Unit, Paris, 75724, France.
Sandrine PassemardPROTECT, INSERM, Unversité Paris Diderot, Sorbonne Paris Cité, Paris, France.
Marco VignuzziInstitut Pasteur, Centre National de la RechercheScientifique UMR 3569, Viral Populations and Pathogenesis Unit, Paris, France.
Pierre GressensPROTECT, INSERM, Unversité Paris Diderot, Sorbonne Paris Cité, Paris, France. pierre.gressens@inserm.fr.
Ferdinando Di CuntoDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Turin, Turin, Italy. ferdinando.dicunto@unito.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors wish to point out that the name of the first author is appearing incorrectly on Pubmed: it should be El Ghouzzi V (and not Ghouzzi VE). In addition, the words "and p53" appear at the end of the title in the original publication ( https://www.nature.com/articles/cddis2016266 ) and in the previous erratum version ( https://www.nature.com/articles/cddis2016446 ). This is not correct.

Identifiers

PMID30459303
PMCPMC6244162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.